Role of human papillomavirus testing in reducing the number of surgical treatments for precancerous cervical lesions

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 427-430

  Vrtacnik Bokal E ^a   Rakar, S ^a   Jancar N ^a   Mozina A ^a   Poljak, M ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

HPV testing; Human papillomavirus; Precancerous cervical lesion; Surgical treatment

Indexed keywords

ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRECANCER; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS;

EID: 23744482386     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pohar-Marinsek Z., Pogacnik A.: "Cytopathology in Slovenia". Cytopathology, 2004, 15, 1, 53.
2. Cancer incidence in Slovenia 2000. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Slovenia, 2003.
3. Parkin D.M.: "Global cancer statistics in the year 2000". Lancet Oncol., 2001, 2, 9, 533.
4. Parkin D.M., Bray F.I., Devesa S.S.: "Cancer burden in the year 2000. The global picture". Eur. J. Cancer, 2001, 37 (suppl. 8), S4.
5. Lutz J.M., Francisci S., Mugno E., Usel M., Pompe-Kirn V., Coebergh J.W. et al.: "Cancer prevalence in Central Europe: the EUROPREVAL Study". Ann. Oncol., 2003, 14, 2, 313.
6. Wright T.C. Jr., Cox J.T., Massad L.S., Carlson J., Twiggs L.B., Wilkinson E.J.: "2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia". Am. J. Obstet. Gynecol., 2003, 189, 1, 295.
7. Wright T.C. Jr., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J.: "2001 Consensus Guidelines for the management of women with cervical cytological abnormalities". JAMA, 2002, 287, 16, 2120.
8. Syrjanen K.J.: "Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV)". Eur. J. Obstet. Gynecol. Reprod. Biol., 1996, 65, 1, 45.
9. Iatrakis G., Kourounis G., Georgopoulos N., Karachotzitis J.: "Treatment delay and pathology results in women with low-grade squamous intraepithelial lesions. A preliminary study". Eur. J. Gynaecol. Oncol., 2004, 25, 3, 376.
10. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 1, 12.
11. Bosch F.X., Munoz N.: "The viral etiology of cervical cancer". Virus. Res., 2002, 89, 2, 183.
12. Poljak M., Brencic A., Seme K., Vince A., Marin I.J.: "Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer". J. Clin. Microbiol., 1999, 37, 3, 796.
13. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J. et al.: "Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results". JAMA, 1999, 281, 17, 1605.
14. Manos M.M.: "HPV testing for clarifying borderline cervical smear results". Br. Med. J., 2001, 322, 7291, 878.
15. Lytwyn A., Sellors J.W., Mahony J.B., Daya D., Chapman W., Ellis N. et al.: "Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV effectiveness in Lowgrade Paps (HELP) Study No. 1 Group". C.M.A.J., 2000, 163, 6, 701.
16. Petry K.U., Menton S., Menton M., van Loenen-Frosch F., de Carvalho Gomes H., Holz B. et al.: "Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients". Br. J. Cancer, 2003, 88, 10, 1570.
17. Wright T.C. Jr., Schiffman M.: "Adding a test for human papillomavirus DNA to cervical-cancer screening". N. Engl. J. Med., 2003, 348, 6, 489.
18. Wright T.C. Jr., Schiffman M., Solomon D., Cox J.T., Garcia F., Goldie S. et al.: "Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening". Obstet. Gynecol., 2004, 103, 2, 304.
19. Agnantis N.J., Sotiriadis A., Paraskevaidis E.: "The current status of HPV DNA testing". Eur. J. Gynaecol. Oncol., 2003, 24, 5, 351.
20. Kim J.J., Wright T.C., Goldie S.J.: "Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance". J.A.M.A., 2002, 287, 18, 2382.
21. Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D. et al.: "Management of women who test positive for high-risk types of human papillomavirus: the HART study". Lancet, 2003, 362, 9399, 1871.
22. Nieminen P., Vuorma S., Viikki M., Hakama M., Anttila A.: "Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer". Br. J. Obstet. Gynaecol., 2004, 111, 8, 842.
23. Vrtačnik-Bokal E., Rakar S., Možina A., Poljak M.: "Human papilloma virus infection in relation to mild dyskaryosis in conventional cervical cytology". Eur. J. Gynaecol. Oncol. (accepted for publication).